AtriCure, Inc. (ATRC) Return on equity 2016–2025
AtriCure, Inc. (ATRC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-2.3%FY2025 · since FY2016: -19.8% → -2.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2.3% | +7.4 pp |
| FY2024 | -9.7% | -3.2 pp |
| FY2023 | -6.5% | +3.6 pp |
| FY2022 | -10.2% | -20.6 pp |
| FY2021 | 10.4% | +22.1 pp |
| FY2020 | -11.7% | +2.6 pp |
| FY2019 | -14.2% | -5.8 pp |
| FY2018 | -8.5% | +8.2 pp |
| FY2017 | -16.7% | +3.1 pp |
| FY2016 | -19.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice